TERAMO – A plenary session of the 2022 European Conference of the “Tissue Engineering and Regenerative Medicine International Society (TERMIS)”, which ended on 1 July in Krakow, was dedicated to the European project of the University of Teramo entitled Perspectives for Future Innovation in Tendon Repair – P4fit (Perspectives for future innovation in tendon repair) with a central report given by Barbara Barboni, Rector’s delegate for the development of Higher Education in Research. The central theme of the Conference was the “Perspectives and Challenges in Regenerative Medicine” in line with the mission of the Society which is a world leader in promoting tissue engineering to improve patient outcomes globally.
“The more than 2000 researchers and scientists who attended the Conference after a two-year break – explained Barbara Tramps – they had the opportunity to meet, network, learn and share innovative ideas in an exponentially growing sector, bringing together experts in cell biology, biomaterials, biofabrication, 3D tissue and organ development, numerical and experimental methods and clinical applications. There are two young researchers from the University of Teramo who distinguished themselves at the Conference. The post doc Maria Rita citeroni was selected for a presentation in the prestigious ‘Novel strategies to assess cellular response to biomaterials’ session, thus having the opportunity to present a research topic of our University in front of an audience of experts which aims to identify the role of GRAPHENE OXIDE, an emerging material, in modulating the immunomodulatory properties of stem cells and thus making them more performing during tissue regeneration processes “.
“Equally relevant – continued Barboni – the recognition received by our doctoral student Adrián Cerveró-Varona which was selected from over 500 posters presented at the Conference and awarded at the end of the conference as the second best poster. Also in this case the topic was aimed at understanding the immunomodulatory mechanisms of stem cells with the practical aim of artificially activating them to produce mediums enriched with bioactive molecules to be used in tendon regenerative medicine treatments “.
–
